Cancer Genetics Posts 42 Percent Increase in Q3 Revenues | GenomeWeb

NEW YORK (GenomeWeb News) – Cancer Genetics said after the close of the market on Wednesday that revenues in its third quarter rose 42 percent year over year.

The cancer diagnostics firm reported revenues of $1.7 million for the three months ended Sept. 30, compared to $1.2 million in the year-ago period. Test volume in the recently completed quarter rose 71 percent year over year to 2,920 from 1,704.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: weighting scheme increases GWAS power, and more.

Marc Tessier-Lavigne is to be the next president of Stanford University.

In Cell this week: characterization of functional genomic features in breast cancer cell lines, epigenetic pattern linked to obesity, and more.

President Obama's proposed budget for fiscal year 2017 includes an increase for NIH, but seeks some of it as mandatory funding.

Mar
03
Sponsored by
Agilent Technologies

This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies.